OSCR
Oscar Health, Inc.
OSCR offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
SHOP
Shopify Inc.
SHOP has the edge over OSCR overall, supported by stronger valuation and stronger modeled upside.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
SHOP Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Strong |
SHOP's revenue, profitability, cash flow and balance sheet are all currently healthy.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR has the edge over SHOP in the historical PE scenario, which offers more potential upside but is not a forecast.
SHOP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 67x | $147 | — |
| Cheap | 78x | $129 | -12% |
| Current | 89x | $147 | — |
| Fair | 107x | $177 | +21% |
| Expensive | 338x | $557 | +280% |
Historical ranges are pointers, not guarantees.
SHOP's PE is in its cheap range at 89x. If earnings grow as analysts expect, today's price would be 67x next year's earnings.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
OSCR has the edge over SHOP on the outlook, with more favorable profitability expectations.
SHOP Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| Low |
Analysts expect strong earnings and revenue growth for SHOP, with profitability holding steady. However, they disagree widely on these estimates.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has returned to profit: it earned $2.47 per share over the past year, after losing money the year before.
SHOP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.20 | +33% |
| Q3 2026 | $1.65 | +21% |
| Q2 2026 | $1.49 | -17% |
| Q1 2026 | $1.02 | -18% |
| Q4 2025 | $0.94 | -40% |
| Q3 2025 | $1.36 | +27% |
| Q2 2025 | $1.80 | +84% |
| Q1 2025 | $1.24 | +$1.41 |
| Q4 2024 | $1.56 | +1633% |
SHOP has the edge over OSCR on earnings, with more consistent year-over-year improvement.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over SHOP on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR's operating margin was 3.5% last quarter, up 7.8 points from the same quarter a year ago.
SHOP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +32% |
| Q2 2026 | $3.6B | +34% |
| Q1 2026 | $3.2B | +34% |
| Q4 2025 | $3.7B | +31% |
| Q3 2025 | $2.8B | +32% |
| Q2 2025 | $2.7B | +31% |
| Q1 2025 | $2.4B | +27% |
| Q4 2024 | $2.8B | +31% |
SHOP's revenue has grown year over year every quarter since late 2020: $3.7B last quarter, up 32% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +3.1 points |
| Q2 2026 | 14% | +2.8 points |
| Q1 2026 | 12% | +3.5 points |
| Q4 2025 | 17% | +0.6 points |
| Q3 2025 | 12% | -1 points |
| Q2 2025 | 11% | -0.9 points |
| Q1 2025 | 8.6% | +4 points |
| Q4 2024 | 17% | +3.1 points |
SHOP has the edge over OSCR on profitability, with a higher operating margin.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR usually generates cash, though not every quarter: the latest was −$1.2B, but it generated $4.1B over the past year.
SHOP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $816M | +61% |
| Q2 2026 | $654M | +55% |
| Q1 2026 | $476M | +31% |
| Q4 2025 | $715M | +17% |
| Q3 2025 | $507M | +20% |
| Q2 2025 | $422M | +27% |
| Q1 2025 | $363M | +56% |
| Q4 2024 | $611M | +37% |
SHOP has the edge over OSCR on cash flow, with more consistent year-over-year improvement.
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
SHOP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -7.2M shares |
| 1 year | -1.7% | -22.1M shares |
| 3 years | -0.4% | -5.1M shares |
| 5 years | +1.1% | +14.5M shares |
| Available history | +11% | +130M shares |
SHOP has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $562M |
| Q2 2026 | $1.4B |
| Q1 2026 | $491M |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has the edge over SHOP on leverage, with a lower net debt burden relative to earnings.
SHOP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.9x | Net Cash |
| Q2 2026 | -0.9x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.7x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
SHOP has more cash than debt.
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
SHOP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.4 | Neutral |
| Stochastic | 51.5 | Neutral |
SHOP's weekly RSI is 52 (neutral) and its Stochastic is 52 (neutral).
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR has the edge over SHOP on valuation relative to its sector.
SHOP PE vs Technology Sector
| Metric | SHOP | Sector median | Relative |
|---|---|---|---|
| PE | 89x | 28x | 219% above |
| PE % | 29 | 35 | 6 pts below |
SHOP is trading at 89x earnings, a 219% premium to the Technology sector's median of 28x.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over SHOP on trend strength, trading above more of its moving averages.
SHOP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $157.0 | 6.5% below |
| 20 week MA | $143.1 | 2.5% above |
| 50 week MA | $134.4 | 9.2% above |
| 100 week MA | $128.1 | 15% above |
| 200 week MA | $97.7 | 50% above |
SHOP's trend is up, with a small recent dip: it's below only its 8-week average, and 50% above its 200-week average.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over SHOP on returns for 2026, with the stronger performance.
SHOP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $40.8 | $122.6 | +200% |
| 2021 | $122.6 | $143.9 | +17% |
| 2022 | $143.9 | $33.7 | -77% |
| 2023 | $33.7 | $77.9 | +131% |
| 2024 | $77.9 | $108.2 | +39% |
| 2025 | $108.2 | $170.8 | +58% |
| 2026 YTD | $170.8 | $146.8 | -14% |
SHOP's yearly returns have swung widely, from +200% in 2020 to −77% in 2022. It's down 14% so far in 2026.